CTRI/2023/11/060051尚未招募Unknown
Study Of Prevalence of Non-Alcoholic Fatty Liver Disease in young individuals with Type II and Type I Diabetes in Central India. - NI
Dr. Sanjeev Gulati0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Subjects will be included in the study if they meet all of the following criteria:
- •1. Overweight (BMI >23) and obese Individuals diagnosed with type 1 or type II diabetes mellitus (T1DM & T2DM) in Central India.
- •2. Adult males and females aged from Age 18 to 35 years, both inclusive.
- •3. Willingness to provide informed consent to participate in the study.
排除标准
- •Subjects will be deemed ineligible to participate in the study if he/she fulfils any of the following criteria:
- •1. History of excessive alcohol consumption (prescribed upper safe limit for men is up to 21 units of alcohol per week, and up to 14 units of alcohol for women. 1 unit is equal to 10 ml of absolute alcohol).
- •2. Presence of viral liver diseases (such as hepatitis B or C).
- •3. Presence of other known liver diseases apart from non-alcoholic fatty liver disease (NAFLD).
- •4. Women subject that are pregnant or lactating, or subject (including male subjects) having a pregnancy plan (including plans for sperm donation or egg donation) during the study period.
研究者
相似试验
尚未招募
不适用
Association of liver disease with obesity in people having diabetics.CTRI/2019/06/019672Batra Hospital and Medical Research Centre
尚未招募
2 期
To study the effect of Safuf-e-Zaranbad in patients with Non-Alcoholic Fatty Liver DiseaseCTRI/2023/03/050355Central Council for Research in Unani Medicine New Delhi
尚未招募
不适用
on alcoloholic liver disease in people living with HIVCTRI/2020/01/022630Maulana Azad Medical College
尚未招募
不适用
Research of Non-alcoholic fatty liver disease(NAFLD) and Non-alcoholic steatohepatitis(NASH) using the measuring instrument of ethanol metabolismJPRN-UMIN000024594Department of hepatology and pancreatology, Aichi Medical University90
进行中(未招募)
不适用
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, LiverCirrhosis, LiverType 1 DiabetesNCT04595474Joslin Diabetes Center533
